Abstract:Recent findings have revealed that aberrant miR-125a-5p expression is involved in the development of atherosclerosis. The present study aimed to investigate the precise mechanism of microRNA (miR)-125a-5p in atherosclerosis. Human vascular smooth muscle cells (HVSMCs) were treated with 20 mu g/ml oxidized low-density lipoprotein (ox-LDL) for 24 h and were employed as in vitro models of atherosclerosis. Reverse transcription quantitative (RT-qPCR) assays were used to detect miR-125a-5p levels. Immunofluorescence analysis was conducted to assess alpha-smooth muscle actin (alpha-SMA) expression. Western blotting and RT-qPCR assays were performed to measure the expression levels of NACHT, LRR and PYD domains-containing protein 3 (NLRP3), apoptosis associated speck-like protein (ASC), caspase-1, active interleukin (IL)-1 beta and C-C motif chemokine 4-like (CCL4). Furthermore, the association between miR-125a-5p and CCL4 was assessed using a double luciferase analysis. In addition, VSMCs were transfected with miR-125a-5p mimics (30 nM), miR-125a-5p inhibitor (100 nM) or small interfering RNA against CCL4 (si-CCL4, 50 pM), respectively to further investigate the function of miR-125a-5p in ox-LDL-treated HVSMCs. The present study found that the expression levels of miR-125a-5p were significantly downregulated in HVSMCs, whereas the expression levels of alpha-SMA, NLRP3, ASC, caspase-1, IL-1 beta and CCL4 were markedly upregulated following ox-LDL treatment. Overexpression of miR-125a-5p in the absence of ox-LDL treatment decreased NLRP3, IL-1 beta and CCL4 expression, whereas inhibition of miR-125a-5p exhibited the opposite effects. The results of double luciferase analysis confirmed that CCL4 was a direct target of miR-125a-5p. Moreover, transfection of si-CCL4 into HVSMCs significantly decreased the ox-LDL-induced expression of NLRP3, ASC, caspase-1 and IL-1 beta proteins. Taken collectively, the results of the present study suggested that miR-125a-5p could negatively regulate the NLRP3 inflammasome by targeting CCL4 in ox-LDL-treated HVSMCs. The data provide new insight to the inhibition of atherosclerosis progression.

Microrna-125a/B-5p Inhibits Endothelin-1 Expression in Vascular Endothelial Cells

MicroRNA-125a-mediated Regulation of the Mevalonate Signaling Pathway Contributes to High Glucose-Induced Proliferation and Migration of Vascular Smooth Muscle Cells

MicroRNA-125a-5p alleviates the deleterious effects of ox-LDL on multiple functions of human brain microvessel endothelial cells

Mir-125A-5p Inhibits the Expression of NLRP3 by Targeting CCL4 in Human Vascular Smooth Muscle Cells Treated with Ox-Ldl

MicroRNA-125a-3p affects smooth muscle cell function in vascular stenosis

Abstract P640: Endogenous Micrornas in Human Microvascular Endothelial Cells Regulate Mrnas Encoded by Hypertension-Related Genes and Are Functionally Important

Upregulation of MicroRNA-125b Leads to the Resistance to Inflammatory Injury in Endothelial Progenitor Cells

Abstract 162: MicroRNAs Mediate the Hemodynamic Regulation of Endothelium-to-Smooth Muscle Signaling

Exosomes from mesenchymal stem cells expressing miR-125b inhibit neointimal hyperplasia via myosin IE.

Microvesicles-mediated communication between endothelial cells modulates, endothelial survival, and angiogenic function via transferring of miR-125a-5p.

The up-regulation of endothelin-1 and down-regulation of miRNA-125a-5p, -155, and -199a/b-3p in human atherosclerotic coronary artery.

Inhibition Effect of Microrna-124 on Rat Vascular Smooth Muscle Cell Proliferation and Its Molecular Mechanism

miR-125a-5p impairs endothelial cell angiogenesis in aging mice via RTEF-1 downregulation.

Microrna-125a-5p Partly Regulates the Inflammatory Response, Lipid Uptake, and Orp9 Expression in Oxldl-Stimulated Monocyte/Macrophages

Essential Role of MicroRNA-155 in Regulating Endothelium-Dependent Vasorelaxation by Targeting Endothelial Nitric Oxide Synthase

microRNA-15b-5p Regulates Vascular Endothelial Growth Factor Signaling Through VEGFR2 in Human Umbilical Vein Endothelial Cells

MicroRNA-27a/b Mediates Endothelin-1-induced PPARγ Reduction and Proliferation of Pulmonary Artery Smooth Muscle Cells

Downregulation of Mirna-1-3p Modulates Cyclic Stretch-Mediated Proliferation of Vascular Smooth Muscle Cells Through Regulation of ETS-1

The Antagonistic Effects and Mechanisms of Microrna‐26a Action in Hypertensive Vascular Remodelling

Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration

MiR155-5p in Adventitial Fibroblasts-Derived Extracellular Vesicles Inhibits Vascular Smooth Muscle Cell Proliferation Via Suppressing Angiotensin-Converting Enzyme Expression